Department of Rehabilitation, Xinhong Community Health Service Center, Shanghai, China.
Hospital Dean's Office, Xinhong Community Health Service Center, Shanghai, China.
Arch Phys Med Rehabil. 2020 Nov;101(11):1991-2001. doi: 10.1016/j.apmr.2020.04.017. Epub 2020 May 20.
To evaluate the effects of respiratory muscle training in a population of stroke patients.
The following databases were searched for clinical trials through December 2019: PubMed, EMBASE, Cochrane Library, CINAHL, and China National Knowledge Infrastructure.
Randomized controlled trials (N=9) published in English met the inclusion criteria.
Data were extracted and assessed for accuracy by 2 reviewers. Any disagreements were resolved after discussions with an independent third reviewer. The quality of the included randomized controlled trials was assessed using the Cochrane bias tool.
The meta-analysis showed increased maximal inspiratory pressure (standardized mean difference [SMD], 0.88; 95% confidence interval [CI], 0.62-1.15; P<.001; 12-wk follow-up period: SMD, 0.94; 95% CI, 0.42-1.45; P<.001), maximal expiratory pressure (SMD, 0.83; 95% CI, 0.15-1.52; P=.017; 12-wk follow-up period: SMD, 0.99; 95% CI, 0.47-1.51; P<.001), forced expiratory volume in 1 second (SMD, 1.41; 95% CI, 0.57-2.24; P=.001), forced vital capacity (SMD, 1.36; 95% CI, 0.55-2.16; P<.001), peak expiratory flow (SMD, 0.74; 95% CI, 0.16-1.32; P=.013), 6-minute walk test (SMD, 0.67; 95% CI, 0.11-1.23; P=.020), and decreased respiratory complications (odds ratio, 0.55; 95% CI, 0.30-1.00; P=.050) compared with no respiratory intervention or a sham intervention.
Respiratory muscle training improved poststroke muscle strength and the benefits were carried over for up to 12 weeks, including improved lung function, walking capacity, and a reduced risk of respiratory impediments.
评估呼吸肌训练对脑卒中患者的影响。
通过 2019 年 12 月对以下数据库进行了临床试验检索:PubMed、EMBASE、Cochrane 图书馆、CINAHL 和中国知网。
符合纳入标准的以英语发表的随机对照试验(N=9)。
由 2 位评审员提取数据并评估准确性。任何分歧均在与独立的第三方评审员讨论后得到解决。使用 Cochrane 偏倚工具评估纳入的随机对照试验的质量。
荟萃分析显示,最大吸气压力(标准化均数差 [SMD],0.88;95%置信区间 [CI],0.62-1.15;P<.001;12 周随访期:SMD,0.94;95% CI,0.42-1.45;P<.001)、最大呼气压力(SMD,0.83;95% CI,0.15-1.52;P=.017;12 周随访期:SMD,0.99;95% CI,0.47-1.51;P<.001)、1 秒用力呼气量(SMD,1.41;95% CI,0.57-2.24;P=.001)、用力肺活量(SMD,1.36;95% CI,0.55-2.16;P<.001)、呼气峰流速(SMD,0.74;95% CI,0.16-1.32;P=.013)、6 分钟步行试验(SMD,0.67;95% CI,0.11-1.23;P=.020)和降低呼吸并发症(比值比,0.55;95% CI,0.30-1.00;P=.050)均优于无呼吸干预或假干预。
呼吸肌训练改善了脑卒中后肌肉力量,并且这种益处可以持续长达 12 周,包括改善肺功能、步行能力和降低呼吸障碍的风险。